ASHP Injectable Drug Information November 2023 Update

This update contains 5 new monographs, 47 revised monographs, 7 new MedWatch alerts and 2 discontinued monographs.

New monographs: Ibalizumab-uiyk; Rezafungin Acetate; Sulbactam Sodium and Durlobactam Sodium; Teplizumab-mzwv; Ublituximab-xiiy.

Revised monographs:  Acetaminophen; Amikacin Sulfate; Amiodarone Hydrochloride; Amphotericin B; ASHP Injectable Drug Information – References; ASHP Injectable Drug Information – Table of Contents; ASHP Injectable Drug Information – Users Guide;  Atracurium Besylate; Azithromycin; Caspofungin Acetate; Ceftolozane sulfate-tazobactam sodium; Chloramphenicol Sodium Succinate; Cisatracurium Besylate; Decitabine; Dexmedetomidine Hydrochloride; Diazepam; Digoxin; Etoposide; Fenoldopam Mesylate; Fentanyl Citrate; Fluconazole; Fosphenytoin Sodium; Furosemide; Gentamicin Sulfate; Heparin Sodium; Hetastarch in Lactated Electrolyte; Hydromorphone Hydrochloride; Imipenem-Cilastatin Sodium; Ketorolac Tromethamine; Levetiracetam; Mepivacaine Hydrochloride; Milrinone Lactate; Nesiritide; Norepinephrine Bitartrate; Octreotide Acetate; Oxaliplatin; Oxycodone Hydrochloride; Piperacillin Sodium-Tazobactam Sodium; Propofol; Ranitidine Hydrochloride; Remdesivir; Reteplase; Streptomycin Sulfate; Tobramycin Sulfate; Vancomycin Hydrochloride; Vasopressin; Verapamil Hydrochloride.

Discontinued monographs: Dolasetron Mesylate; Quinidine Gluconate.

New MedWatch alerts on the following monographs:  Lidocaine Hydrochloride; Sodium Bicarbonate.

Removed MedWatch alerts on the following monographs:  Acyclovir Sodium; Enoxaparin Sodium; Idarubicin Hydrochloride;  Sodium Acetate; Topotecan Hydrochloride.